Conference
Phase II study of sorafenib (BAY 43-9006) in combination with gemcitabine in recurrent epithelial ovarian cancer: A study of the PMH phase II consortium.
Authors
Welch S; Hirte H; Schilder R; Townsley C; Tinker L; Pond G; Afinec A; Wright J; Oza A
Volume
11
Pagination
pp. 9059S-9059S
Publisher
AMER ASSOC CANCER RESEARCH
Publication Date
December 15, 2005
Name of conference
AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics
Conference place
Philadelphia, PA
Conference start date
November 14, 2005
Conference end date
November 18, 2005
Conference proceedings
CLINICAL CANCER RESEARCH
Issue
24
ISSN
1078-0432